Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Brain Derived Neurotrophic Factor (BDNF) Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease

NCT04012411 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04012411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04012411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Brain Derived Neurotrophic Factor (BDNF) Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Recruiting
Start date
March 3, 2020
Completion date
September 30, 2027
Enrollment
135 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease